{"id":"cilazapril","rwe":[{"pmid":"41353285","year":"2025","title":"Cilazapril and benazepril mitigate neurodegeneration and α-synuclein accumulation in a cellular model of parkinson's disease.","finding":"","journal":"Scientific reports","studyType":"Clinical Study"},{"pmid":"40657379","year":"2025","title":"Repurposing Antidiabetic Drugs for Gangrene: A Mendelian Randomization and Text Mining Study.","finding":"","journal":"International journal of medical sciences","studyType":"Clinical Study"},{"pmid":"38399287","year":"2024","title":"Simultaneously Predicting the Pharmacokinetics of CES1-Metabolized Drugs and Their Metabolites Using Physiologically Based Pharmacokinetic Model in Cirrhosis Subjects.","finding":"","journal":"Pharmaceutics","studyType":"Clinical Study"},{"pmid":"37759279","year":"2023","title":"How do we define high and low dose intensity of heart failure medications: a scoping review.","finding":"","journal":"BMC cardiovascular disorders","studyType":"Clinical Study"},{"pmid":"37193115","year":"2023","title":"Protolytic equilibria of ACE inhibitors in micellar solution of nonionic surfactant Brij 35.","finding":"","journal":"Monatshefte fur chemie","studyType":"Clinical Study"}],"tags":[{"label":"cilazapril","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Angiotensin-converting enzyme","category":"target"},{"label":"ACE","category":"gene"},{"label":"C09AA08","category":"atc"},{"label":"Active","category":"status"},{"label":"Hypertensive disorder","category":"indication"},{"label":"Angiotensin-Converting Enzyme Inhibitors","category":"pharmacology"},{"label":"Antihypertensive Agents","category":"pharmacology"},{"label":"Cardiovascular Agents","category":"pharmacology"},{"label":"Enzyme Inhibitors","category":"pharmacology"},{"label":"Protease Inhibitors","category":"pharmacology"}],"phase":"phase_2","safety":{"safetySignals":[{"llr":293.929,"date":"","count":63,"signal":"Amaurosis fugax","source":"DrugCentral FAERS","actionTaken":"Reported 63 times (LLR=294)"},{"llr":255.525,"date":"","count":63,"signal":"Urinary tract disorder","source":"DrugCentral FAERS","actionTaken":"Reported 63 times (LLR=256)"},{"llr":253.229,"date":"","count":64,"signal":"Ocular discomfort","source":"DrugCentral FAERS","actionTaken":"Reported 64 times (LLR=253)"},{"llr":244.192,"date":"","count":68,"signal":"Haemorrhagic stroke","source":"DrugCentral FAERS","actionTaken":"Reported 68 times (LLR=244)"},{"llr":239.587,"date":"","count":71,"signal":"Head discomfort","source":"DrugCentral FAERS","actionTaken":"Reported 71 times (LLR=240)"},{"llr":219.703,"date":"","count":86,"signal":"Tinnitus","source":"DrugCentral FAERS","actionTaken":"Reported 86 times (LLR=220)"},{"llr":188.275,"date":"","count":65,"signal":"Generalised oedema","source":"DrugCentral FAERS","actionTaken":"Reported 65 times (LLR=188)"},{"llr":187.114,"date":"","count":63,"signal":"Photophobia","source":"DrugCentral FAERS","actionTaken":"Reported 63 times (LLR=187)"},{"llr":167.92,"date":"","count":68,"signal":"Altered state of consciousness","source":"DrugCentral FAERS","actionTaken":"Reported 68 times (LLR=168)"},{"llr":167.715,"date":"","count":64,"signal":"Blindness","source":"DrugCentral FAERS","actionTaken":"Reported 64 times (LLR=168)"},{"llr":164.053,"date":"","count":64,"signal":"Diplopia","source":"DrugCentral FAERS","actionTaken":"Reported 64 times (LLR=164)"},{"llr":155.981,"date":"","count":64,"signal":"Presyncope","source":"DrugCentral FAERS","actionTaken":"Reported 64 times (LLR=156)"},{"llr":152.066,"date":"","count":63,"signal":"Eye pain","source":"DrugCentral FAERS","actionTaken":"Reported 63 times (LLR=152)"},{"llr":150.608,"date":"","count":66,"signal":"Haematemesis","source":"DrugCentral FAERS","actionTaken":"Reported 66 times (LLR=151)"},{"llr":143.758,"date":"","count":70,"signal":"Haematuria","source":"DrugCentral FAERS","actionTaken":"Reported 70 times (LLR=144)"}],"commonSideEffects":[{"effect":"Amaurosis fugax","drugRate":"LLR 294","severity":"common"},{"effect":"Urinary tract disorder","drugRate":"LLR 256","severity":"common"},{"effect":"Ocular discomfort","drugRate":"LLR 253","severity":"common"},{"effect":"Haemorrhagic stroke","drugRate":"LLR 244","severity":"common"},{"effect":"Head discomfort","drugRate":"LLR 240","severity":"common"},{"effect":"Tinnitus","drugRate":"LLR 220","severity":"common"},{"effect":"Generalised oedema","drugRate":"LLR 188","severity":"common"},{"effect":"Photophobia","drugRate":"LLR 187","severity":"common"},{"effect":"Altered state of consciousness","drugRate":"LLR 168","severity":"common"},{"effect":"Blindness","drugRate":"LLR 168","severity":"common"},{"effect":"Diplopia","drugRate":"LLR 164","severity":"common"},{"effect":"Presyncope","drugRate":"LLR 156","severity":"common"},{"effect":"Eye pain","drugRate":"LLR 152","severity":"common"},{"effect":"Haematemesis","drugRate":"LLR 151","severity":"common"},{"effect":"Haematuria","drugRate":"LLR 144","severity":"common"}]},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"vascace","offLabel":[],"synonyms":["cilazapril monohydrobromide","cilazapril anhydrous","cilazapril","inhibace","vascace","cilazapril monohydrate","cilazapril hydrate"],"timeline":[],"approvals":[],"brandName":"Vascace","ecosystem":[{"indication":"Hypertensive disorder","otherDrugs":[{"name":"acebutolol","slug":"acebutolol","company":"Promius Pharma"},{"name":"aliskiren","slug":"aliskiren","company":"Novartis"},{"name":"amiloride","slug":"amiloride","company":"Paddock Llc"},{"name":"amlodipine","slug":"amlodipine","company":"Pfizer"}],"globalPrevalence":null}],"mechanism":{"target":"Angiotensin-converting enzyme","targets":[{"gene":"ACE","source":"DrugCentral","target":"Angiotensin-converting enzyme","protein":"Angiotensin-converting enzyme"}],"modality":"Small Molecule","drugClass":"cilazapril","explanation":"Imagine your blood vessels are like roads in a city. Angiotensin II is like a traffic cop that makes the roads narrower, increasing blood pressure. Cilazapril removes this traffic cop, allowing the roads to stay open and blood pressure to decrease.","oneSentence":"Cilazapril blocks the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor.","technicalDetail":"Cilazapril inhibits the angiotensin-converting enzyme (ACE), a peptidyl dipeptidase that converts angiotensin I to angiotensin II, a potent vasoconstrictor, thereby reducing peripheral resistance and lowering blood pressure."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/641","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=CILAZAPRIL","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CILAZAPRIL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:00:47.209716","biosimilars":[],"competitors":[{"drugName":"captopril","drugSlug":"captopril","fdaApproval":"1981-04-06","genericCount":21,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"enalapril","drugSlug":"enalapril","fdaApproval":"1985-12-24","patentExpiry":"Nov 6, 2032","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"lisinopril","drugSlug":"lisinopril","fdaApproval":"1987-12-29","patentExpiry":"Nov 6, 2035","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"perindopril","drugSlug":"perindopril","fdaApproval":"1993-12-30","genericCount":5,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ramipril","drugSlug":"ramipril","fdaApproval":"1991-01-28","patentExpiry":"Aug 16, 2039","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"quinapril","drugSlug":"quinapril","fdaApproval":"1991-11-19","genericCount":12,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"benazepril","drugSlug":"benazepril","fdaApproval":"1991-06-25","genericCount":12,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"fosinopril","drugSlug":"fosinopril","fdaApproval":"1991-05-16","genericCount":10,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"trandolapril","drugSlug":"trandolapril","fdaApproval":"1996-04-26","genericCount":10,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"spirapril","drugSlug":"spirapril","fdaApproval":"1994-12-29","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"moexipril","drugSlug":"moexipril","fdaApproval":"1995-04-19","genericCount":4,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"cilazapril","indications":{"approved":[{"name":"Hypertensive disorder","source":"DrugCentral","snomedId":38341003,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"captopril","brandName":"captopril","genericName":"captopril","approvalYear":"1981","relationship":"same-class"},{"drugId":"enalapril","brandName":"enalapril","genericName":"enalapril","approvalYear":"1985","relationship":"same-class"},{"drugId":"lisinopril","brandName":"lisinopril","genericName":"lisinopril","approvalYear":"1987","relationship":"same-class"},{"drugId":"perindopril","brandName":"perindopril","genericName":"perindopril","approvalYear":"1993","relationship":"same-class"},{"drugId":"ramipril","brandName":"ramipril","genericName":"ramipril","approvalYear":"1991","relationship":"same-class"},{"drugId":"quinapril","brandName":"quinapril","genericName":"quinapril","approvalYear":"1991","relationship":"same-class"},{"drugId":"benazepril","brandName":"benazepril","genericName":"benazepril","approvalYear":"1991","relationship":"same-class"},{"drugId":"fosinopril","brandName":"fosinopril","genericName":"fosinopril","approvalYear":"1991","relationship":"same-class"},{"drugId":"trandolapril","brandName":"trandolapril","genericName":"trandolapril","approvalYear":"1996","relationship":"same-class"},{"drugId":"spirapril","brandName":"spirapril","genericName":"spirapril","approvalYear":"1994","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT07262710","phase":"","title":"Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study","status":"NOT_YET_RECRUITING","sponsor":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","startDate":"2025-12-01","conditions":["Post-stroke Pneumonia"],"enrollment":13656,"completionDate":"2026-08-19"},{"nctId":"NCT02817360","phase":"PHASE4","title":"NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients","status":"RECRUITING","sponsor":"Martin Huelsmann","startDate":"2016-02","conditions":["Heart Diseases","Diabetes Mellitus, Type 2"],"enrollment":2400,"completionDate":"2026-12"},{"nctId":"NCT00528385","phase":"NA","title":"Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System","status":"COMPLETED","sponsor":"Medical University of Gdansk","startDate":"2005-03","conditions":["Chronic Kidney Disease","Proteinuria"],"enrollment":0,"completionDate":""},{"nctId":"NCT00378443","phase":"NA","title":"ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT","status":"UNKNOWN","sponsor":"Peking University","startDate":"2006-01","conditions":["Glomerulonephritis, IGA"],"enrollment":0,"completionDate":"2007-06"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000171771","NDDF":"003950","UNII":"19KW7PI29F","VUID":"4025239","CHEBI":"CHEBI:145568","VANDF":"4025239","INN_ID":"5675","RXNORM":"152491","UMLSCUI":"C0055723","ChEMBL_ID":"CHEMBL515606","KEGG_DRUG":"D01069","DRUGBANK_ID":"DB01340","PUBCHEM_CID":"56330","SNOMEDCT_US":"1268982005","IUPHAR_LIGAND_ID":"6459","SECONDARY_CAS_RN":"92077-78-6","MESH_DESCRIPTOR_UI":"D017315","MESH_SUPPLEMENTAL_RECORD_UI":"C045980"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"60%"},"publicationCount":563,"therapeuticAreas":["Cardiovascular"],"atcClassification":{"source":"DrugCentral","atcCode":"C09AA08","allCodes":["C09AA08","C09BA08"]},"biosimilarFilings":[],"recentPublications":[{"date":"2025 Dec 6","pmid":"41353285","title":"Cilazapril and benazepril mitigate neurodegeneration and α-synuclein accumulation in a cellular model of parkinson's disease.","journal":"Scientific reports"},{"date":"2025","pmid":"40657379","title":"Repurposing Antidiabetic Drugs for Gangrene: A Mendelian Randomization and Text Mining Study.","journal":"International journal of medical sciences"},{"date":"2024 Feb 5","pmid":"38399287","title":"Simultaneously Predicting the Pharmacokinetics of CES1-Metabolized Drugs and Their Metabolites Using Physiologically Based Pharmacokinetic Model in Cirrhosis Subjects.","journal":"Pharmaceutics"},{"date":"2023 Sep 27","pmid":"37759279","title":"How do we define high and low dose intensity of heart failure medications: a scoping review.","journal":"BMC cardiovascular disorders"},{"date":"2023","pmid":"37193115","title":"Protolytic equilibria of ACE inhibitors in micellar solution of nonionic surfactant Brij 35.","journal":"Monatshefte fur chemie"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Vascace is a small molecule inhibitor of the angiotensin-converting enzyme. It works by inhibiting the angiotensin-converting enzyme, which is involved in blood pressure regulation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}